KLING DOUGLAS F

PrivateCIK: 1699022
Location

BEDMINSTER, NJ

KLING DOUGLAS F (Chief Operating Officer) sold 69.1% of their position (98.61K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market

Open‑market sale worth $2.10M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 3 sales
InsiderKLING DOUGLAS FCIK 1699022
Officer· Chief Operating Officer
Since Dec 2023
-98.61K
Net shares
Net seller
$2.10M
Total sold
3
Open market trades
0B · 3S
7
Total transactions
98.61K acquired · 197.22K disposed
Non-Derivative Transactions5

Ordinary Shares

Direct
M · Option Exercise

Shares

+47.57K

Price / share

$10.90

Trade value

$518.50K

% of position

108.1%
7/15/2025
44K91.57K

Ordinary Shares

Direct
S · Sale

Shares

44.02K

Price / share

$21.38

Trade value

$941.25K

% of position

48.1%
7/15/2025
91.57K47.54K

Ordinary Shares

Direct
S · Sale

Shares

3.54K

Price / share

$22.12

Trade value

$78.39K

% of position

7.5%
7/15/2025
47.54K44K

Ordinary Shares

Direct
M · Option Exercise

Shares

+51.04K

Price / share

$10.90

Trade value

$556.37K

% of position

116.0%
7/16/2025
44K95.04K

Ordinary Shares

Direct
S · Sale

Shares

51.04K

Price / share

$21.10

Trade value

$1.08M

% of position

53.7%
7/16/2025
95.04K44K
Total

Net shares

+0.00

Net value

-$1.02M

Derivative Transactions2

Option (right to buy)

Direct
M · Option Exercise
Converts to

Ordinary Shares

47.57K shares

Shares

47.57K

Strike price

10.90

Held after

213.75K

Exercisable

7/15/2025

Option (right to buy)

Direct
M · Option Exercise
Converts to

Ordinary Shares

51.04K shares

Shares

51.04K

Strike price

10.90

Held after

162.70K

Exercisable

7/16/2025
KLING DOUGLAS F — Insider Transaction (Form 4) Filed Jul 17, 2025 | Finecho